SS
Shivani Srivastava
Hematology & Oncology
Credentials: ·
Research
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
New England Journal of Medicine · 2022 · 1,574 citations
Engineering CAR-T cells: Design concepts
Review · Trends in Immunology · 2015 · First of 2 authors · 384 citations
Cancer Cell · 2019 · First of 11 authors · Corresponding · 283 citations
10 papers
8 papers
6 papers
5 papers
5 papers
5 papers
- RN
4 papers
3 papers
